Dr. Rahul Kushwah reports

PREDICTMEDIX AI'S 2023 BREAKTHROUGHS: PIONEERING HEALTHCARE INNOVATION AND GLOBAL EXPANSION

Predictmedix AI Inc. has provided an update on its achievements and developments so far in 2023. Predictmedix AI, a leader in AI-driven healthcare solutions, has achieved remarkable milestones and advancements this year, revolutionizing the healthcare landscape through cutting-edge technology, technology validations, and strategic commercialization efforts.

"Predictmedix AI is proud to have achieved significant advancements this year, solidifying our position as a leader in AI-driven healthcare solutions. Our dedication to innovation, validated technology, and strategic partnerships underscores our commitment to revolutionizing patient care and safety on a global scale," commented Dr. Rahul Kushwah, COO of Predictmedix.

Technological Advancements:

• Comprehensive Triage Solution: Predictmedix's Triage Solution has expanded to encompass 16 vital parameters, including temperature, heart rate, BMI, blood pressure, and more, enhancing its accuracy and versatility in the Healthcare landscape. Learn More
• Unprecedented Dataset: Over 200,000 individuals have been scanned using AI-powered Safe Entry Stations, creating an unparalleled dataset for accurate analysis. This milestone advances machine learning accuracy across healthcare and other industries. Read More
• Cardiovascular Parameters Measurement: Predictmedix introduces ground-breaking technology to measure heart rate variability, respiration rate, and blood pressure non-invasively. Learn More
• Diabetes Screening Innovation: Innovating diabetes screening without the need for biological fluids, expanding diagnostic reach in India. Discover More
• Revolutionary Fitness Scan: Predictmedix introduces a first-to-market fitness scan vertical using advanced machine learning algorithms, enabling athletes to optimize training and performance. Learn More
• US Patent for Impairment Screening: A US patent granted for AI-powered impairment detection technology for alcohol and cannabis screening. Read More

Technology Validation:

• Independent Clinical Validation: Predictmedix's technology validated in independent hospitals and universities in India and Indonesia, establishing its credibility in healthcare settings.
• International Recognition: Major newspapers in India and Indonesia feature Predictmedix's technology for its cost-saving and efficiency-improving capabilities in healthcare.

Value Proposition with Safe Entry Stations:

Predictmedix's Safe Entry Stations transform healthcare efficiency, offering significant benefits such as:

• Labor Cost Reduction: Automating screenings reduces manual effort, freeing staff for critical tasks.
• Efficient Patient Flow: Faster screenings lead to reduced wait times and increased patient throughput.
• Preventive Measures: Proactively identifying potential risks prevents contagious outbreaks.
• Resource Allocation Optimization: Accurate identification of symptomatic individuals enables better resource allocation.
• Legal and Liability Mitigation: Early detection minimizes legal liabilities and reputational damage.
• Improved Infection Control: Preventing symptomatic individuals enhances infection control and patient outcomes.

Commercialization and Business Development:

• Indonesia and ASEAN Market: Predictmedix taps into the vast market potential in Indonesia and the ASEAN region, collaborating with prestigious institutions for tailored research and development. Learn More
• Indian Healthcare Opportunity: Predictmedix capitalizes on India's growing healthcare needs, forging collaborations with government officials and departments. Read More
• Indian Subsidiary: "Predictmedix India Pvt Ltd" is established to expedite collaborations and development in India.
• Strategic Supplier Partnership: Engagement with an Indian supplier for mass production of Safe Entry Stations enhances production capacity and accessibility.

As Predictmedix AI continues its journey to redefine healthcare through innovation, validated technology, and strategic global expansion, the company remains committed to its vision of a safer, more efficient, and accessible healthcare landscape for all. With a strong foundation of achievements in 2023, including expanded solutions, international recognition, and partnerships, Predictmedix AI is poised to lead the charge in AI-driven healthcare solutions. The company invites stakeholders, industry leaders, and the global community to join in this transformative journey toward a healthier and more secure future.

About Predictmedix AI Inc.

Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedi AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.

We seek Safe Harbor.